Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-02-03Clinical Trial Update: Ultrasound Shear Wave Elastography in Parkinson's Disease
A clinical trial is evaluating ultrasound shear wave elastography in Parkinson disease. The study is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: Investigation of Dual-Task Exercise's Effect in Parkinson's Disease [NA]
A completed clinical trial evaluating the effect of dual-task exercise in Parkinson's disease as reported on ClinicalTrials.gov (NCT06803212…
-
CLINICAL_TRIALS other · 2025-01-31Clinical Trial Update: Observational Small Intestine and Blood Fingerprint (SmIle) Study in Parkinson's Disease
An observational study called SmIle investigating the small intestine and blood fingerprints in Parkinson disease; the trial is currently ac…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Effectiveness of Attention/executivefunctions Training on Prospective Memory Abilities of Parkinson's Disease Subjects with Mild Cognitive Impairment and Healthy Aged Individuals: a Placebo-controlled Study with a Combined Immersive Virtual Reality and Telemedicine Approach [NA]
A completed placebo-controlled clinical trial assesses whether immersive virtual reality and telemedicine-based attention and executive func…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II) [Phase 1]
University of California, San Diego is conducting a Phase 1/2 clinical trial to test CT1-DAP001, human iPS cell-derived dopaminergic progeni…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Expanded Access Using Allogeneic Bone-marrow Derived Human Mesenchymal Stem Cells (Allo-hMSC) for a Individual Parkinson's Disease Subject
Expanded access update describing treatment with allogeneic bone-marrow derived human mesenchymal stem cells (Allo-hMSC) for a single Parkin…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Evaluation of Dysphagia in Patients Diagnosed With Parkinson's Disease by Ultrasound
A completed clinical trial evaluating the use of ultrasound to evaluate dysphagia in patients with Parkinson disease.
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Relative Bioavailability Study of HNC364 Injectable Suspension [Phase 1]
Phase 1 relative bioavailability study of HNC364 Injectable Suspension for Parkinson's disease, sponsored by Guangzhou Henovcom Bioscience C…
-
CLINICAL_TRIALS research · 2025-01-29Clinical Trial Update: Possibilities of Use MRI-Guided Laser Interstitial Thermal Therapy in Medically Intractable Tremor [NA]
This clinical trial update describes the investigation of MRI-guided Laser Interstitial Thermal Therapy for medically intractable tremor, in…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Investigation of Validity and Reliability of the Minnesota Manual Dexterity Test in Parkinson's Disease
A completed clinical trial investigates whether the Minnesota Manual Dexterity Test is valid and reliable for assessing dexterity in Parkins…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Freezing of Gait - Clinical Outcomes Assessment
A clinical trial focusing on freezing of gait in Parkinson's disease is currently recruiting and evaluating clinical outcomes assessment.
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: A Clinical Study Evaluating Efficacy of Pirepemat on Falls Frequency in Patients with Parkinson's Disease (PD) [Phase 2]
Phase 2 clinical trial evaluating the efficacy of Pirepemat in reducing falls among Parkinson's disease patients has completed.
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Effect of Food and Age on the Pharmacokinetics of LY03017 [Phase 1]
This update describes a Phase 1 pharmacokinetic study of LY03017 evaluating the effects of food and age on its pharmacokinetics.
-
CLINICAL_TRIALS research · 2025-01-24Clinical Trial Update: Effect of Biological Sex on Multimodal Biomarkers of Disease Progression in Patients with Parkinson's Disease
A clinical trial protocol assessing whether biological sex influences multimodal biomarkers of Parkinson disease progression, with status no…
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: A Study of CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update reporting results for CST-2032 and CST-107 in individuals with mild cognitive impairment or mild dementia due …
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Effects of Gait Training With and Without PNF on Balance ,Gait and Activities of Daily Living in Parkinson's Patients [NA]
This completed clinical trial evaluated the effects of gait training with and without proprioceptive neuromuscular facilitation on balance, …
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Tributyrin Supplementation [Phase 1]
Phase 1 trial evaluating tributyrin supplementation in Parkinson's disease was terminated. Results have been posted.
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: SpiroGym App-Aided Cough Rehabilitation [NA]
A clinical trial update for the SpiroGym app-aided cough rehabilitation study in Parkinson disease is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Learning Potential of Patients With Parkinson's Disease After Two Weeks of Targeted Touchscreen Training [NA]
A clinical trial evaluated whether two weeks of targeted touchscreen training could enhance learning in patients with Parkinson disease; the…
-
CLINICAL_TRIALS research · 2025-01-23Clinical Trial Update: Cohort Study to Identify Predictor Factors of Onset and Progression of Parkinson's Disease
An ongoing French cohort study aims to identify factors that predict the onset and progression of Parkinson disease; the study is currently …
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Clinical, Molecular and by Neuroimaging of LRRK2 Mutations
A completed study evaluating clinical, molecular, and neuroimaging aspects of LRRK2 mutations in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Nucleipark:High Field MR Imaging (7T and 3T) of the Brainstem, the Deep Nuclei and Their Connections in the Parkinsonian Syndromes. Applications to Prognosis, Pathophysiology and Improvement of Therapeutic Strategies
A completed imaging-focused clinical trial evaluating high-field MRI (7T and 3T) of the brain in Parkinsonian syndromes, with aims to improv…
-
EMA approval · 2025-01-22EMA Authorised: Levodopa/Carbidopa/Entacapone Orion (levodopa;carbidopa;entacapone) — Orion Corporation
The European Medicines Agency authorised Levodopa/Carbidopa/Entacapone Orion for the treatment of Parkinson's disease, manufactured by Orion…
-
CLINICAL_TRIALS trial_result · 2025-01-22Clinical Trial Update: Effect on Parkinson's Disease After Therapeutic Induction of CranioSacral Integrated Therapy [NA]
A clinical trial update notes enrollment by invitation for a study evaluating the effect of CranioSacral Integrated Therapy on Parkinson's d…
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Study of the Test-retest Reliability of the Neuropsychiatric Fluctuations Scale in Parkinson's Disease [NA]
This study assesses the test-retest reliability of the Neuropsychiatric Fluctuations Scale in individuals with Parkinson's disease.